Avian coronavirus infectious bronchitis virus susceptibility to botanical oleoresins and essential oils in vitro and in vivo
Article
[키워드] addition
Administering
Botanical extracts
Clinical sign
Compound
coronavirus
CPE, cytopathic effects
Dilution
disease
effective
EID50, 50% embryo infectious dose
ELISA, enzyme linked immunosorbent assay
essential oils
examined
expected
greater
HMA, hexamethylene amiloride
Host
IBV
IBV, infectious bronchitis virus
in vitro
in vivo
Infection
Infectious Bronchitis Virus
investigated
knowledge
Laboratory
lesion
Massachusett
MHV, mouse hepatitis virus
Natural ingredients
Oleoresins
PBS, phosphate buffered saline
protection
reduced
RFLP, restriction fragment length polymorphism
RT-PCR, Reverse transcriptase-polymerase chain reaction
SARS-CoV, Severe Acute Respiratory Syndrome virus
serotype
severity
SPF, specific pathogen free
susceptibility
TCID50, 50% tissue culture infectious dose
Transmission
Treatment
Vero E6 cell
Viral RNA
virucidal
virus
Virus challenge
virus inactivation
virus titer
viruses
was determined
[DOI] 10.1016/j.virusres.2010.01.006 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.virusres.2010.01.006 PMC 바로가기 [Article Type] Article